Skip to main content
Clinical Trials/NCT02435602
NCT02435602
Completed
Not Applicable

The Role of Narrow Band Imaging (NBI) Endoscopy Compared With Lugol Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers: a Prospective Randomized Study

Maria Sklodowska-Curie National Research Institute of Oncology1 site in 1 country294 target enrollmentDecember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal Squamous Cell Carcinoma
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Enrollment
294
Locations
1
Primary Endpoint
Positive predictive value
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study evaluates the role of narrow band imaging (NBI) endoscopy compared with Lugol chromoendoscopy in the early detection of esophageal cancer in patients with prior head and neck cancers.

Detailed Description

Patients with head and neck cancers have an increased risk for developing an esophageal squamous cell carcinoma (ESCC). Small, superficial, curable lesions are difficult to diagnose using only white light endoscopy. To improve detection chromoendoscopy is recommended. In this project patients are divided into two groups based on received chromoendoscopy (NBI versus Lugol). The results of two methods will be compare regarding positive predictive value to establish usage of chromoendoscopy in early detection of ESCC.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
January 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with past history ( \>= 1 year ) of head and neck cancer treated curatively and receiving regular follow - up at the outpatient clinic of the Head and Neck Department of Maria Skłodowska - Curie Memorial Cancer Center, Institiut of Oncology
  • 18 years and older
  • Diagnosis of squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, larynx
  • Zubrod scale 0-2
  • Provided written informed consent

Exclusion Criteria

  • Lack of written informed consent
  • Known allergy to iodine
  • Clinical conditions precluding upper GI endoscopy

Outcomes

Primary Outcomes

Positive predictive value

Time Frame: 2 years

The results of two methods are compare regarding positive predictive value.

Secondary Outcomes

  • Evaluation of endoscopy ( NBI versus Lugol staining) tolerance using Visual Analogue Scale (VAS)(2 years)
  • Duration of the esophagoscopy ( NBI versus Lugol staining)(2 years)

Study Sites (1)

Loading locations...

Similar Trials